1 outlets · filed 10 November 2026
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
What the coverage shows
Both outlets focus on the FDA warning about GLP-1 drugs and the rare vision-loss risk, and both present it as a caution rather than a major confirmed harm. Ars Technica explicitly says the risk appears small and the data are mixed, while 60 Minutes frames the drugs as now carrying a warning about a rare but potentially dangerous side effect. Only 60 Minutes adds the detail that a doctor joins CBS News to discuss it.
Written by Crossfiled from the 1 headlines and extracts below, not from the articles themselves. It describes how the outlets framed this, not what happened. Open any headline for a summary of that article.
How it broke
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
More on Health
- Indonesia factory fire kills three, 36 missing 3 outlets
- Princess of Wales opens up about cancer 2 outlets
- Princess Kate reflects on healing in new documentary: "Cancer does change you" 2 outlets
- Violence breaks out in Mexico after capture of drug kingpin wanted by FBI 2 outlets
